Additionally, numerous studies have indicated that, in addition to its antitumor biological activity, TLR9 can enhance tumour cells' sensitivity to chemotherapy by increasing chemotherapy-induced apoptosis and decreasing tumour cell proliferation [72,73]. This evidence concerns the gene TLR9 and neoplasm.